|
2024 Conference Publication 3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSSBywater, Megan, Zhang, Ranran, Grabek, Julian, Halder, Rohit, Janardhanan, Yashaswini, Cooper, Leanne, Cooper, Emily, Ross, David, Straube, Jasmin and Lane, Steven (2024). 3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSS. EXPHEM 2024, Philadelphia, PA, United States: Elsevier BV. doi: 10.1016/j.exphem.2024.104357 |
|
2023 Conference Publication Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse ModelZhang, Ranran, Janardhanan, Yashaswini, Haldar, Rohit, Cooper, Leanne, Jaquelin, Sebastien, Straube, Jasmin, Bywater, Megan and Lane, Steven W. (2023). Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-188150 |
|
2019 Conference Publication Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in childrenLi, Yizhen, Qian, Maoxiang, Devidas, Meenakshi, Yang, Wentao, Winter, Stuart S., Dunsmore, Kimberly P., Smith, Colton A., Lin, Ting-Nien, Zhao, Xuijie, Zhang, Ranran, Foster, Julie M. Gastier, Raetz, Elizabeth A., Carroll, William L., Rabin, Karen R., Yang, Wenjian, Zweidler-McKay, Patrick A., Pui, Ching-Hon, Evans, William E., Mullighan, Charles G., Hunger, Stephen P., Relling, Mary V., Loh, Mignon L. and Yang, Jun J. (2019). Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in children. 61st Annual Meeting of the American-Society-of-Hematology (ASH), Orlando, FL, United States, 7-10 December 2019. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2019-125912 |
|
2016 Conference Publication Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapyZhang, Ranran, Fenggui, Wei, Chen, Ru, Liang, Ming, Wu, Liping, Zhang, Hui and Chen, Fuxiong (2016). Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapy. 58th ASH Annual Meeting, San Diego, CA United States, 3-6 December 2016. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v128.22.1580.1580 |
